Drawing for WEST

USPTO serial 86957724

WEST

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
NADELMAN, ANDREA KOYNER
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with WEST?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rex A. Donnelly

Rex A. Donnelly BUCHANAN INGERSOLL & ROONEY, PC2200 Renaissance Boulevard, Suite 350King of Prussia, PA 19406United States

Goods and services

ClassDescriptionStatusFirst use
005Infusion pumps, sold pre-filled, for facilitating subcutaneous delivery of a wide range of liquid pharmaceutical preparations to patients; infusion pumps sold pre-filled with fluids used for the subcutaneous delivery of pharmaceutical preparations to patients; infusion pumps for delivering liquid pharmaceutical preparations to patients, sold pre-filled with pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; infusion pumps for delivering liquid pharmaceutical preparations to patients, sold pre-filled with insulinACTIVE—
009Computer application software for mobile phones and handheld computers, namely, interactive patient engagement and medication adherence software for users of wearable injector drug delivery systems; Computer software for facilitating communication between a computer or handheld device connected to the internet and an wearable injector drug delivery system; Downloadable mobile applications for communicating with an wearable injector drug delivery system and for displaying health related informationACTIVE—
035Arranging and conducting incentive reward programs for promoting consumer compliance with prescriptions for medications delivered by wearable injector drug delivery systems; Providing an interactive web site that offers participants rewards for providing information about health and fitness in the nature of their health programs, personal health data and prescription and health conditions, for data collection used in improving healthcare administration and cost management in connection with wearable injector drug delivery systemsACTIVE—
038Broadcast communication services, namely, transmitting emails and text messages notifications to designated recipients for others, namely, alerts, reminders and information related to compliance with health programs relating to wearable injector drug delivery systemsACTIVE—
042Computer services, namely, providing an interactive web site featuring technology that allows users to communicate information from wearable injector drug delivery systems; Providing temporary use of non-downloadable computer software for communicating with wearable injector drug delivery systems and for displaying health related information; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports relating to wearable injector drug delivery systems; Providing on-line non-downloadable software for authenticating and rewarding compliance with health programs, namely, prescriptions for medications and medical treatment regimens related to wearable injector drug delivery systems; Providing on-line non-downloadable software for users to receive notifications via e-mail, instant message, short message service (SMS), multimedia message service (MMS) or text messages relating to wearable injector drug delivery systemsACTIVE—
044Medical information services, namely providing via a website and e-mail and text message notifications, medical information related to compliance with health programs relating to wearable injector drug delivery systemsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 29, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 29, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 15, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 2, 2025EX5GSOU EXTENSION 5 GRANTED—
May 29, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 13, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 12, 2025EXT5SOU EXTENSION 5 FILED—
Aug 23, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 23, 2024EX4GSOU EXTENSION 4 GRANTED—
Aug 23, 2024EXT4SOU EXTENSION 4 FILED—
Aug 23, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 24, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 23, 2024EX3GSOU EXTENSION 3 GRANTED—
Feb 23, 2024EXT3SOU EXTENSION 3 FILED—
Feb 23, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 24, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 22, 2023EX2GSOU EXTENSION 2 GRANTED—
Aug 22, 2023EXT2SOU EXTENSION 2 FILED—
Aug 22, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 23, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 21, 2023EX1GSOU EXTENSION 1 GRANTED—
Feb 21, 2023EXT1SOU EXTENSION 1 FILED—
Feb 21, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 23, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 28, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 28, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 8, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 18, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 4, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 3, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 3, 2022ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Nov 4, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Nov 4, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 4, 2021CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 4, 2021RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Oct 9, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 9, 2020GNSLLETTER OF SUSPENSION E-MAILED—
Oct 9, 2020CNSLSUSPENSION LETTER WRITTEN—
Mar 23, 2020RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Sep 9, 2019RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Feb 25, 2019RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Aug 23, 2018RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Feb 22, 2018RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Feb 22, 2018ALIEASSIGNED TO LIE—
Aug 7, 2017RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Feb 7, 2017GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 7, 2017GNSLLETTER OF SUSPENSION E-MAILED—
Feb 7, 2017CNSLSUSPENSION LETTER WRITTEN—
Jan 18, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 17, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 17, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 25, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 15, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 15, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 15, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 13, 2016DOCKASSIGNED TO EXAMINER—
Apr 5, 2016MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Apr 2, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 2, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance